Synapse - Parastoo Dahi

Results (294)

Early CMV reactivation adversely impacts blood counts recovery at 1 year post-transplant in recipients of CD34(+) selected graft

Meeting Abstract

Tamari, R.; Cho, C.; Hilden, P.; Maloy, M.; Borrill, T.; Politikos, I.; Papanicolaou, G. A.; Jakubowski, A. A.; Gyurkocza, B.; Shaffer, B. C.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Analysis of cytomegalovirus (CMV) infections in the first 180 days in adult sero-positive cord blood transplantation (CBT) recipients reveals high infection rates and treatment burden

Meeting Abstract

Lau, C.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Bhatt, V.; Dahi, P. B.; Perales, M. A.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Prevalence of functional impairment and geriatric vulnerability during pre-transplant geriatric assessment in an academic hematopoietic cell transplantation center

Meeting Abstract

Lin, R. J.; Perales, M. A.; Shahrokni, A.; Maloy, M.; Devlin, S. M.; Jakubowski, A. A.; Dahi, P. B.; Shah, G. L.; Korc-Grodzicki, B.; Giralt, S. A.
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

De novo skin xerosis in cord blood transplantation is associated with distinct histopathology and treatment response: First literature report of cord dermatosis

Meeting Abstract

Markova, A.; Pulitzer, M.; Jain, M.; Dierov, D.; Dahi, P. B.; Gyurkocza, B.; Sauter, C. S.; Spitzer, B.; Barker, J. N.; Ponce, D. M.
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma

Meeting Abstract

Dahi, P. B.; Rondon Clavo, C.; Maloy, M.; Seier, K.; Devlin, S. M.; Robinson, K.; Scordo, M.; Shah, G. L.; Tamari, R.; Matasar, M. J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Feasibility and toxicity of Pharmacokinetic (PK)-directed dosing of Evomela® (propylene glycol free melphalan, PGF-MEL) for multiple myeloma (MM) and AL amyloidosis (AL) patients undergoing autologous hematopoietic stem cell transplant (AHCT)

Meeting Abstract

Shah, G. L.; Lin, A.; Schofield, R.; Sarubbi, C.; Preston, E. V.; Devlin, S. M.; Bhatt, V.; Harnicar, S.; Hoover, E.; Chung, D. J.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)

Meeting Abstract

Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel Cy/ Flu/ Thio/ TBI 400 intermediate intensity conditioning regimen

Meeting Abstract

Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)